- Home
- Companies
- Zynex, Inc.
- Products
- NeuroMove - Model 900 - Stroke ...
NeuroMove - Model 900 -Stroke Rehabilitation
NeuroMove is a neurological re-learning tool that promotes neuroplasticity and teaches healthy parts of the brain how to take over lost functionality after stroke. NeuroMove is FDA-cleared for stroke rehabilitation, and its use has dramatically ameliorated functional impairments in stroke survivors in many clinical studies and in the clinical practice. It is sophisticated enough to employ in the clinic, yet simple enough for patients to use at home. Utilizing the device 30 minutes daily for 4–5 months has been shown to yield excellent results.
Built-In Battery
Built-in battery which needs to be recharged once a week. Battery requires 80% or higher charge for optimal performance.
Display
Graphical display with 60 seconds of history and a threshold which is automatically adjusted to an attainable goal. The internal processor sets this goal in a very logical fashion and the patient is rewarded for attempts which exceed the previous level.
Detection
The NeuroMove is so sensitive, it can detect attempts to move a muscle even before neuron firing can cause visible contractions of muscle fibers. The self-adjusting feature of the NeuroMove not only adjusts to every individual patient, but also adjusts to every new treatment session.
Different Modes
A mode specifically for spinal cord injury patients, with an EMG setting that is 5 times more sensitive than that of the stroke mode.
- EMG sensitivity: 0.25 – 1000 μV RMS
- Output Current: 0-100 mA into 1.0 K ohm
- Sample Rate: 3,300 samples per second
- Pulsewidth: 50 – 400 μs
- Frequency: 2 – 160 Hz
- Time on: 0.5 – 30 sec.
- Time off: 0.1 – 60 sec.
- Ramp-up and down: 0.1 – 6 sec.
- Waveform: Biphasic.